Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 6/20 | 0.64 |
| ▸ | FABP3 | P05413 | 2/20 | 0.64 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.64 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16604550 | 0.85 | FABP4 (0.58) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL24220091 | 0.82 | FABP4 (0.68) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL8989764 | 0.82 | FABP4 (0.69) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL162818 | 0.80 | FABP4 (0.67) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL8243105 | 0.80 | FABP4 (0.67) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL456464 | 0.80 | FABP4 (0.67) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL12983353 | 0.78 | FABP4 (0.64) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL17318094 | 0.78 | FABP4 (0.64) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL15139221 | 0.78 | FABP4 (0.64) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL86091 | 0.78 | FABP4 (1.00) | FABP4FABP3FABP5GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119219810-A | Ionic polymer and preparation method and application thereof | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| JP-63267754-A | — | — | None | — | — | JP | disclosed |
| US-12303544-B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | ZYMEWORKS BC INC. (CA) | 2025-05-20 | — | — | US | disclosed |
| CN-119219810-A | Ionic polymer and preparation method and application thereof | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119219809-A | Fluorine-containing polymer, preparation method thereof and ion exchange membrane | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-118812398-A | Bissulfonylimide compound, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2024-10-22 | — | — | CN | disclosed |
| CN-117903016-A | Fluorosulfonyl sulfonimide salt, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2024-04-19 | — | — | CN | disclosed |
| US-20230390354-A1 | CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME | ZYMEWORKS BC INC. (CA) | 2023-12-07 | — | — | US | disclosed |
| CN-110143999-B | Cytotoxic and antimitotic compounds and methods of use thereof | 酵活英属哥伦比亚省公司 | 2023-12-05 | — | — | CN | disclosed |
| US-11617777-B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | ZYMEWORKS BC INC. | 2023-04-04 | — | — | US | disclosed |
| US-20030052310-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2003-03-20 | — | — | US | disclosed |
| EP-0850920-B1 | Ionic conductive materials comprising salts of perfluorinated amides and uses thereof | CENTRE NAT RECH SCIENT (FR) | 2002-09-11 | — | — | EP | disclosed |
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2002-01-24 | — | — | US | disclosed |
| US-6319428-B1 | Perfluorinated amide salts and their uses as ionic conducting materials | HYDRO-QUEBEC (CA) | 2001-11-20 | — | — | US | disclosed |
| WO-1998029388-A1 | PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS | HYDRO-QUEBEC (CA) | 1998-07-09 | — | — | WO | disclosed |
| JP-S63267754-A | BENZAMIDE DERIVATIVE AND SOIL DISEASE-CONTROLLING AGENT | NISSAN CHEM IND LTD | 1988-11-04 | — | — | JP | disclosed |
| EP-0194599-A2 | Benzamide derivatives, process for producing the same, and soil fungicides containing the same | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-09-17 | — | — | EP | disclosed |
| EP-0069585-B1 | COLOR-FORMING SULFONAMIDODIPHENYLAMINES, PHOTOGRAPHIC ELEMENTS CONTAINING THEM AND CORRESPONDING SULFONIMIDE DYES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-07-03 | — | — | EP | disclosed |
| US-4499304-A | COLOR PHOTOGRAPHY;SILVER HALIDE EMULSIONS; PRINTING PLATES; IMAGES | EASTMAN KODAK COMPANY (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0069585-A1 | Color-forming sulfonamidodiphenylamines, photographic elements containing them and corresponding sulfonimide dyes | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | AFF4, NHERF1, AFF2 | FABP4 305/4885FABP3 1258/4885FABP5 200/4885 |
| US-11617777-B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | CCNB1, PLK1, BOD1L1 | FABP4 4403/4885FABP3 4628/4885FABP5 4314/4885 |
| US-12303544-B2 | Cytotoxic and anti-mitotic compounds, and methods of using the same | CCNB1, PLK1, BOD1L1 | FABP4 4403/4885FABP3 4628/4885FABP5 4314/4885 |
| US-20230390354-A1 | CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME | CCNB1, PLK1, BOD1L1 | FABP4 4403/4885FABP3 4628/4885FABP5 4314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.